Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) General Counsel Philip Mazzara sold 4,380 shares of the firm's stock in a transaction on Monday, November 16th. The stock was sold at an average price of $206.62, for a total value of $904,995.60. Following the completion of the sale, the general counsel directly owned 92,190 shares of the company's stock, valued at $19,048,297.80. This trade represents a 4.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Astera Labs Stock Performance
Shares of NASDAQ ALAB traded up $5.15 during trading on Wednesday, hitting $216.75. 4,545,870 shares of the company were exchanged, compared to its average volume of 5,136,489. The company has a fifty day moving average price of $290.56 and a 200-day moving average price of $257.51. The firm has a market capitalization of $37.88 billion, a PE ratio of 86.35 and a beta of 3.85. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48.
Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.13. Astera Labs had a net margin of 29.64% and a return on equity of 25.35%. The firm had revenue of $584.90 million during the quarter, compared to analysts' expectations of $550.78 million. During the same period last year, the business earned $0.49 earnings per share. Astera Labs's revenue was up 153.6% compared to the same quarter last year. Research analysts anticipate that Astera Labs, Inc. will post 2.99 earnings per share for the current fiscal year.
Recent Astera Labs Headlines
These are some of the ALAB headlines that stood out recently:
Institutional Investors Weigh In On Astera Labs
Several institutional investors and hedge funds have recently modified their holdings of the company. BlackRock Inc. acquired a new stake in shares of Astera Labs during the 2nd quarter worth about $6,609,581,000. Atreides Management LP increased its stake in Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock valued at $368,890,000 after purchasing an additional 1,754,593 shares during the last quarter. Van ECK Associates Corp increased its stake in Astera Labs by 20.0% in the second quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company's stock valued at $1,080,980,000 after purchasing an additional 373,545 shares during the last quarter. Bank of America Corp DE purchased a new position in Astera Labs in the second quarter valued at approximately $1,061,791,000. Finally, Amundi raised its holdings in Astera Labs by 77.9% during the first quarter. Amundi now owns 1,880,830 shares of the company's stock worth $206,139,000 after purchasing an additional 823,477 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on the company. Weiss Ratings downgraded Astera Labs from a "buy (b-)" rating to a "hold (c)" rating in a research report on Friday, October 23rd. Susquehanna cut their price objective on Astera Labs from $310.00 to $258.00 and set a "neutral" rating for the company in a research report on Wednesday, November 4th. BMO Capital Markets assumed coverage on shares of Astera Labs in a research report on Thursday, November 5th. They issued an "outperform" rating and a $375.00 target price on the stock. UBS Group lowered their target price on shares of Astera Labs from $300.00 to $290.00 and set a "neutral" rating for the company in a research note on Wednesday, November 4th. Finally, Jefferies Financial Group boosted their price target on shares of Astera Labs from $270.00 to $450.00 and gave the company a "buy" rating in a research note on Wednesday, August 5th. Thirteen analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $320.85.
View Our Latest Report on ALAB
Astera Labs Company Profile
(
Get Free Report)
Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company's portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.